Anirban Sengupta1, Anup Singh1, Sumeet Agarwal2, Pradeep Kumar Gupta3, and Rakesh Kumar Gupta3
1Centre for Biomedical Engineering, IIT Delhi, New Delhi, India, 2Electrical Engineering, IIT Delhi, New Delhi, India, 3Radiology, Fortis Memorial Research Institute, New Delhi, India
Synopsis
Differentiation
of non-enhancing tumor from surrounding vasogenic edema is critical for
planning tumor surgery as well as radiation therapy. Most studies suggested
that histology results should be taken as ground truth instead of
radiologist’s decision for validating results. This study is an attempt to
differentiate vasogenic-edema from non-enhancing tumor based upon pre and
post-surgery MRI images using a SVM classifier. DCE-MRI obtained perfusion
parameters were used for classification. A misclassification
error of 2.4 % was obtained for differentiating between non-enhancing tumor and
edema using a SVM classifier followed by smoothing in post-processing step.
Introduction
The
current standard for the radiologist’s assessment in patients with high-grade
Glioma(HGG) relies on the Response-Assessment-in-Neuro-Oncology(RANO) criteria1 which expands upon
the earlier Macdonald-criteria2, to incorporate
the non-enhancing component of the tumor, as this component may indicate
infiltrative or diffuse tumor growth. Most studies involving differentiation
between vasogenic-edema and non-enhancing tumor(NET) takes radiologist based
tumor delineation as ground truth3–5. However, analysis by radiologist are found to
be subjective and there remains both inter and intra-rater differences6–8. Most studies
have concluded that a histological
spatial comparison involving samples obtained at surgery is needed to validate
the results4,5,9. Post-surgery images provide the most reliable ground truth for validation. This study
attempts to differentiate vasogenic-edema and NET of high-grade glioma(HGG)
patients using a SVM classifier based
upon pre and post-surgery MRI images.Methods
This
study included MRI data from nine HGG patients (having pre-surgery and
post-surgery MRI) and nine Metastasis-patients acquired at Philips 3T MR
scanner. The mean time interval
between pre-op and post-op of 9 Glioma patients was 3 months. MRI
protocol for this study included conventional images for brain tumor patient,
data for pre-contrast T1 maps, and T1-weighted dynamic-contrast-enhanced(DCE)
MRI. DCE-MRI data was analysed using first pass analysis (parameters:
cerebral-blood-volume(CBV), cerebral-blood-flow(CBF)) and generalized tracer
kinetic model (parameters: Ktrans, Ve, Vp, Kep). CBV was
also corrected for leakage (CBV-corr). CBV-Corr and CBF maps were normalized with respect
to white matter tissue (CBF-NWM, CBV-corr-NWM). Perfusion -parameter maps were
obtained using in-house built Matlab
based software. Perfusion-parameters CBF-NWM, CBV-Corr-NWM and Vp were used for further
analysis as the other parameters did not represent NET and vasogenic edema region entirely. Fig(1) provides a flow chart description
of the study. It describes
different steps for obtaining NET and vasogenic-edema followed by histogram
analysis and SVM based classification. Vasogenic-edema
was obtained from Metastasis-patients as there has been literature suggesting
edema obtained from Metastasis-patients can be considered as pure edema10.Results
Fig(2) shows the different segmentation steps
done for obtaining Mask-6 and the map of CBV-Corr-NWM parameter for that slice. It can be
seen that the values of CBV-Corr-NWM are
higher than neighborhood region in the NET region. Fig(3) shows segmentation of vasogenic-edema region from flair images of Metastasis-patients and the corresponding CBV-Corr-NWM map for that slice. It can be seen that CBV-Corr-NWM
values are lower in the vasogenic-edema region than its neighborhood. The histogram distributions of 3 perfusion-parameters
showed that there is some overlap between NET and vasogenic-edema region. CBF-NMW and CBV-Corr-NWM
parameter have a much lesser overlap among the three regions than Vp (result
not shown). The optimal value of C and Gamma for which 9-Fold CV error was minimised was found to be C=1000 and
Gamma=10 (results not shown). ROC curve shown
in Fig(4) shows that SVM classifier with all the perfusion-parameters combined, provides highest area under curve(AUC)
as well as maximum sensitivity and specificity for classification between NET and vasogenic-edema region. After
optimising the SVM classifier with respect to C and Gamma, combined error on
classifying NET and vasogenic-edema came
to ~ 8.3%. It was found that on applying a mean filter on a neighborhood size of 5×5 voxels, misclassification error
for combined HGG patients and Metastasis-patients came down to a minimum of 2.43 % from 8.3% as
shown in Fig(5).Discussion
One limitation of this study was that the pre-surgery MRI scans were not obtained exactly
before the surgery. In order to
overcome this problem, the study was
designed such that only that much of surgeried
region was considered which belonged to Mask-4 in pre-surgery flair images. It should be noted that
subtracted T1GD image has been used for segmentation of Mask-2 and Mask-3 in
this study, as that gives better contrast than post-contrast T1GD image. Another important
point to mention is during pre-surgery,
the entire Mask-1, Mask-2 and Mask-3 is our region of interest (ROI) in this study. Hence, the mean filter has been applied to the entire ROI and not only on NET
region and vasogenic-edema. Thus it can be seen, from Fig(5) that
misclassified labels occurring near the boundary of the labeled NET has been less
rectified less by smoothing as they also had influence from pixels outside the labeled region. However, misclassification was
significantly reduced post-processing
(smoothing) in those areas where surrounding pixels are majorly of opposite class.
Conclusion
This study
proposes an automatic SVM based method for segmenting NET and vasogenic-edema using
post-surgery images as the ground truth. This study would help doctors to
delineate tumor area for planning surgery or radiation-therapy of tumor in HGG patients in a more reliable way.Acknowledgements
The Authors acknowledge technical support of
Philips India Limited in MRI data acquisition. This work was supported by Science and
Engineering Research Board (IN) (YSS/2014/000092).References
1. Wen PY, Macdonald
DR, Reardon DA, et al. Updated response assessment criteria for high-grade
gliomas: Response assessment in neuro-oncology working group. J. Clin. Oncol.
2010;28:1963–1972. doi: 10.1200/JCO.2009.26.3541.
2. Macdonald DR,
Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of
supratentorial malignant glioma. J. Clin. Oncol. [Internet] 1990;8:1277–1280.
doi: 10.1200/JCO.1990.8.7.1277.
3. Blumenthal DT, Artzi
M, Liberman G, Bokstein F, Aizenstein O, Ben Bashat D. Classification of
High-Grade Glioma into Tumor and Nontumor Components Using Support Vector
Machine. Am. J. Neuroradiol. [Internet] 2017;38:908–914. doi:
10.3174/ajnr.A5127.
4. Jensen TR, Schmainda
KM. Computer-aided detection of brain tumor invasion using multiparametric MRI.
J. Magn. Reson. Imaging 2009;30:481–489. doi: 10.1002/jmri.21878.
5. Artzi M, Bokstein F,
Blumenthal DT, Aizenstein O, Liberman G, Corn BW, Ben Bashat D. Differentiation
between vasogenic-edema versus tumor-infiltrative area in patients with
glioblastoma during bevacizumab therapy: A longitudinal MRI study. Eur. J.
Radiol. [Internet] 2014;83:1250–1256. doi: 10.1016/j.ejrad.2014.03.026.
6. Gordillo N, Montseny
E, Sobrevilla P. State of the art survey on MRI brain tumor segmentation. Magn.
Reson. Imaging [Internet] 2013;31:1426–1438. doi: 10.1016/j.mri.2013.05.002.
7. Mazzara GP,
Velthuizen RP, Pearlman JL, Greenberg HM, Wagner H. Brain tumor target volume
determination for radiation treatment planning through automated MRI
segmentation. Int. J. Radiat. Oncol. Biol. Phys. [Internet] 2004;59:300–312.
doi: 10.1016/j.ijrobp.2004.01.026.
8. Luo S, Li R, Orselin
S. A new deformable model using dynamic gradient vector flow and adaptive
balloon forces. APRS Work. Digit. Image Comput. [Internet] 2003:489–490.
9. Artzi M, Blumenthal
DT, Bokstein F, Nadav G, Liberman G, Aizenstein O, Ben Bashat D. Classification
of tumor area using combined DCE and DSC MRI in patients with glioblastoma. J.
Neurooncol. 2015;121:349–357. doi: 10.1007/s11060-014-1639-3.
10.
Fink KR, Fink JR. Imaging of brain metastases. Surg Neurol Int [Internet]
2013;4:S209-19. doi: 10.4103/2152-7806.111298